Marella Thorell - 25 Mar 2024 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
EVP and Chief Financial Officer
Signature
/s//Thomas J. DesRosier, Attorney-in-Fact for Marella Thorell
Issuer symbol
MCRB
Transactions as of
25 Mar 2024
Net transactions value
$0
Form type
4
Filing time
27 Mar 2024, 16:20:09 UTC
Previous filing
08 Nov 2023
Next filing
01 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Options (right to buy) Award $0 +700,000 $0.000000 700,000 25 Mar 2024 Common Stock 700,000 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on March 25, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Remarks:

EVP and Chief Financial Officer